Alterations in plasma pharmacokinetics of cisplatin in tumor-bearing rats Charles L. LitterstRichard Magin Original Articles Pages: 1 - 4
Effect of uridine coadministration on 5′-deoxy-5-fluorouridine disposition in rats J. Lai-Sim AuM. Guillaume WientjesSteven L. Bramer Original Articles Pages: 5 - 10
The comparative tissues distribution of platinum and 14C in mice receiving 14C-labelled carboplatin Sarah E. DibleZahid H. SiddikKenneth R. Harrap Original Articles Pages: 11 - 16
Comparison of glutathione S-transferase activity between drug-resistant and-sensitive human tumor cells: Is glutathione S-transferase associated with multidrug resistance? Keisuke YusaHirofumi HamadaTakashi Tsuruo Original Articles Pages: 17 - 20
Penetration of substances into tumour tissue Thore NedermanJörgen CarlssonKerstin Kuoppa Original Articles Pages: 21 - 25
Enhanced cytotoxicity with methotrexate in conjunction with hypoxanthine in L1210 cells in culture Craig R. FairchildJonathan MaybaumJames A. Straw Original Articles Pages: 26 - 32
Methotrexate administered by 6-h and 24-h infusion: a pharmacokinetic comparison Joseph D. BorsiDezso SchulerPeter J. Moe Original Articles Pages: 33 - 35
The growth-inhibitory effect of 4-hydroperoxycyclophosphamide against human non-small cell lung carcinoma is enhanced by low-dose difluoromethylornithine Diane C. TsaiGordon D. Luk Original Articles Pages: 36 - 40
Comparison of cellular basis of drug sensitivity of human colon, pancreatic, and renal carcinoma cell lines with that of leukemia cell lines Shogo OzawaTetsuya YasudaMakoto Inaba Original Articles Pages: 41 - 46
Dose-dependent pharmacokinetics of flavone acetic acid in mice Giovanna DamiaMaria Luisa ZanetteMaurizio D'Incalci Original Articles Pages: 47 - 50
Resistance and cross-resistance of the IgM immunocytoma in the LOU/M Wsl rat for cisplatin, carboplatin, and iproplatin P. A. SteerenbergC. P. J. VendrikJ. H. Schornagel Original Articles Pages: 51 - 57
Concentration and time dependence of the toxicity of fluorinated pyrimidines to HT 29 colorectal carcinoma cells K. H. LinkK. R. AignerP. V. Danenberg Original Articles Pages: 58 - 62
Phase II trial of fludarabine phosphate (F-Ara-AMP) in patients with advanced breast cancer A. MittelmanR. AshikariZ. Arlin Original Articles Pages: 63 - 64
Salivary concentrations of hexamethylene bisacetamide (HMBA) in patients receiving 5-day continuous infusions Barbara A. ConleyMerrill J. EgorinDouglas E. Peterson Original Articles Pages: 65 - 68
Pharmacokinetics of Anandron in patients with advanced carcinoma of the prostate Lakshmi PendyalaPatrick J. CreavenChristine Bertagna Original Articles Pages: 69 - 76
High activity of mitoxantrone in previously untreated low-grade lymphomas Steen Werner HansenNis I. NissenJens Pedersen-Bjergaard Original Articles Pages: 77 - 79
In vitro chemosensitivity of brain tumors to cisplatin and its analogues, iproplatin and carboplatin Pierre DodionCharlotte SandersYvon Kenis Original Articles Pages: 80 - 82
Uridine pharmacokinetics in cancer patients Thomas C. K. ChanMaurie MarkmanStephen B. Howell Original Articles Pages: 83 - 86
Lack of effect of cisplatin on i. v. L-PAM plasma pharmacokinetics in ovarian cancer patients M. ZucchettiM. D'IncalciC. Sessa Original Articles Pages: 87 - 89
A physiological function for multidrug-resistant membrane glycoproteins: a hypothesis regarding the renal organic cation-secretory system J. Arly Nelson Letter to the Editors Pages: 92 - 93